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Abstract
Background: Customized birth weight charts take into account physiological maternal characteristics that are known
to influence fetal growth to differentiate between physiological and pathological abnormal size at birth. It is unknown
whether customized birth weight charts better identify newborns at risk of long-term adverse outcomes than
population birth weight charts. We aimed to examine whether birth weight classification according to customized charts
is superior to population charts at identification of newborns at risk of adverse cardio-metabolic and respiratory health
outcomes.
Methods: In a population-based prospective cohort study among 6052 pregnant women and their children, we measured
infant catch-up growth, overweight, high blood pressure, hyperlipidemia, liver steatosis, clustering of cardio-metabolic risk
factors, and asthma at age 10. Small size and large size for gestational age at birth was defined as birth weight in
the lowest or highest decile, respectively, of population or customized charts. Association with birth weight classification
was assessed using logistic regression models.
Results: Of the total of 605 newborns classified as small size for gestational age by population charts, 150 (24.8%) were
reclassified as appropriate size for gestational age by customized charts, whereas of the total of 605 newborns classified
as large size for gestational age by population charts, 129 (21.3%) cases were reclassified as appropriate size for gestational
age by customized charts. Compared to newborns born appropriate size for gestational age, newborns born small size for
gestational age according to customized charts had increased risks of infant catch-up growth (odds ratio (OR) 5.15 (95%
confidence interval (CI) 4.22 to 6.29)), high blood pressure (OR 2.05 (95% CI 1.55 to 2.72)), and clustering of
cardio-metabolic risk factors at 10 years (OR 1.66 (95% CI 1.18 to 2.34)). No associations were observed for overweight,
hyperlipidemia, liver steatosis, or asthma. Newborns born large-size for gestational age according to customized charts
had higher risk of catch-down-growth only (OR 3.84 (95% CI 3.22 to 4.59)). The direction and strength of the observed
associations were largely similar when we used classification according to population charts.
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Conclusions: Small-size-for-gestational-age newborns seem to be at risk of long-term adverse cardio-metabolic health
outcomes, irrespective of the use of customized or population birth weight charts.
Keywords: Birth weight, Charts, Child, Outcomes, Customization, Cardiovascular health, Respiratory health
Background
Small size for gestational age (SGA) and large size for
gestational age (LGA) are important risk factors for
adverse perinatal outcomes and death [1]. Children born
SGA or LGA also have increased risks of suboptimal
growth, cardio-metabolic, and respiratory development
throughout childhood, leading to increased risks of
obesity, coronary heart disease, type 2 diabetes, and ob-
structive respiratory disease in later life [2, 3]. Usually,
population birth weight charts, which take into account
gestational age at birth and sex, are used to discriminate
between SGA, appropriate size for gestational age
(AGA), and LGA newborns [4]. Newborns classified as
SGA or LGA by these population charts include those
who have grown according to their physiological growth
potential and end up constitutionally small or large at
birth, and those who have fetal growth restriction or
acceleration and end up pathologically small or large at
birth. Maternal characteristics, such as age, height, body
mass index (BMI), ethnicity and parity, and fetal sex are
important determinants of fetal growth and cause non-
pathological variation in birth weight [5, 6]. Customized
charts take these physiological maternal and fetal char-
acteristics into account for classification of normal and
abnormal weight at birth [7, 8]. Customized charts may
therefore be better able to distinguish constitutionally
from pathologically small or large size for gestational age
at birth newborns [9]. Previous studies assessing the
superiority of customized over population charts to
identify SGA and LGA newborns at risk of short-term
adverse outcomes are scarce and show conflicting re-
sults [10–13].
We hypothesized that compared to population charts,
customized charts can better identify newborns at risk of
long-term adverse health outcomes. We examined in a
population-based prospective cohort study among 6052
newborns the associations of SGA and LGA based on
both customized and population charts for identification
of newborns at risk of adverse growth patterns, cardio-
metabolic, and respiratory risk factors in childhood.
Methods
Study design
This study was embedded in the Generation R Study, a
population-based prospective cohort study from early
pregnancy onwards in Rotterdam, the Netherlands [14].
The study has been approved by the local Medical
Ethical Committee (MEC 198.782/2001/31). Written
consent was obtained from all participating women. All
pregnant women were enrolled between 2001 and 2005.
Response rate at birth was 61%. Eight thousand eight
hundred seventy-nine women enrolled during preg-
nancy. We excluded non-singleton live births (n = 246),
participants without information on weight and gesta-
tional age at birth or maternal characteristics needed to
generate customized charts (n = 2004), and children with-
out long-term outcomes available (n = 577). The popula-
tion for analysis comprised 6052 mothers and their
children (Additional file 1, Figure S1). Additional file 2
contains a Strengthening the Reporting of Observational
Studies in Epidemiology (STROBE) statement for the
current study [15].
Classification of birth weight by customized and
population charts
Customized charts have been developed within our
study cohort as described previously and include gesta-
tional age, fetal sex, maternal parity, age, height, weight,
and ethnicity [7]. The pathological determinant maternal
smoking was also used for the development of the
customized charts because it has a substantial effect on
fetal growth and birth weight and led to a more accurate
regression model [7]. For the construction of a custom-
ized growth chart, the term for smoking was set to zero,
whether the pregnant woman smoked or not. Hereby,
non-smoking was used as reference category within our
customized models. To calculate the customized birth
weight percentile, we entered the maternal characteris-
tics, fetal sex, and gestational age at birth for each
newborn within our customized charts model and
compared actual birth weight to the expected weight.
For the population charts, we used gestational age ad-
justed weight charts modeled on the same population
[7]. We calculated the birth weight percentile, by enter-
ing gestational age at birth for each newborn within our
population charts’ model, and compared actual birth
weight to the expected weight. The population chart
only included gestational age and no other characteris-
tics, which allows for the optimal comparison between
the population charts and customized charts in which
any difference in outcome would only be explained by
the process of customization. The formulas for both the
customized charts and population charts have been
published previously [7]. If the observed birth weight for
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gestational age was < 10th or > 90th percentile of the
customized or population chart, the newborn was classi-
fied as SGA or LGA respectively, otherwise AGA. We
compared classifications according to customized and
population charts and further defined customized and
population only SGA and LGA newborns. “Customized
only” SGA or LGA newborns are classified as AGA by
population charts but reclassified as SGA or LGA by
customized charts. “Population only” SGA or LGA new-
borns are classified as AGA by customized charts but
reclassified as SGA or LGA by population charts. Mode
of delivery, offspring sex, gestational age, weight, and
APGAR score were obtained from medical records [16].
Preterm birth was defined as a gestational age of < 37
weeks at birth.
Childhood growth, cardio-metabolic, and respiratory
outcomes
Well-trained staff in the Community Health Centers ob-
tained postnatal growth characteristics at the age of 12
months and was available for 4205 (69.5%) participants.
Catch-up and catch-down growth for weight was defined
as an increase or decrease of > 0.67 SD of weight from
birth to 12months of age [17]. This change represents the
width of each percentile band on standard growth charts.
At the age of 10 years, children were invited for de-
tailed measurements. We measured height and weight
without shoes and heavy clothing. We calculated sex-
and age-adjusted childhood BMI SDS based on Dutch
reference growth charts (Growth Analyzer 4.0 Dutch
Growth Research Foundation) and categorized BMI into
normal, overweight, and obesity using the definition of
Cole et al. [18, 19]. Total body fat and lean mass were
measured with a dual-energy X-ray absorptiometry
(DXA) scanner (iDXA, Ge-Lunar, 2008, Madison, WI,
USA) using encore software version 13.6. Fat mass index
(FMI) was calculated: fat mass (kg)/height(m)2. Children
were scanned using a 3.0 Tesla MRI (Discovery MR750w,
GE Healthcare, Milwaukee, WI, USA) using standard
protocols [20]. Visceral fat volumes were generated by
summing volumes and multiplying by the gravity of adi-
pose tissue, 0.9 g/ml. Liver fat fraction was determined by
the average mean signal intensities from four samples of
at least 4 cm2 from the central portion of the hepatic
volume. Liver steatosis was defined as liver fat fraction ≥
5.0%. Blood pressure was measured four times in supine
position, with 1-min intervals at the right brachial artery
using the automatic sphygmomanometer Datascope
Accutor Plus (Paramus, NK) [21]. The mean of the last
three measurements was calculated to determine blood
pressure. High blood pressure was defined as systolic or
diastolic blood pressure > 90th percentile, using sex-, age-,
and height-specific cut-points [22]. Non-fasting venous
blood samples were collected to measure total cholesterol,
high-density lipoprotein (HDL)-cholesterol, triglycerides,
and insulin concentrations using Cobas 8000 analyzer
(Roche, Almere, the Netherlands). Recommendations
from National Cholesterol Education Program for chil-
dren age 2–9 were used to define adverse levels of total
cholesterol (> 5.1 mmol/l) [23]. For clustering of cardio-
metabolic risk factors, we used the definition of childhood
metabolic syndrome phenotype, which is having three or
more of the following components: visceral fat mass >
75th percentile, systolic or diastolic blood pressure > 75th
percentile, HDL-cholesterol < 25th percentile or triglycer-
ides > 75th percentile, and insulin level > 75th percentile
of our study population [24].
Forced expiratory volume in the first second (FEV1),
forced vital capacity (FVC), FEV1:FVC, and forced ex-
piratory flow after expiring 75% of FVC (FEF75) were
measured by spirometry (MasterScreen-Pneumo, Jaeger
Toennies (Viasys) CareFusion Netherlands) [25]. Mea-
sures were converted into sex-, height-, age-, and
ethnicity-adjusted SDS according to the Global Lung
Initiative reference data [26]. Asthma was defined as
ever physician-diagnosed asthma at age 10, obtained by
parental reported questionnaires.
Statistical analyses
First, each newborn was classified into birth weight
categories using both customized and population classifi-
cations. Descriptive data of birth weight categories were
compared. Second, the percentages of newborns reclassi-
fied as SGA or LGA by customized charts only or popula-
tion charts only were assessed and population
characteristics were compared using one-way ANOVA for
continuous and chi-square test for categorical variables.
Third, we assessed the associations of SGA and LGA at
birth according to both customized and population charts
with adverse outcomes using linear and logistic regression
models for continuous and categorical outcomes, respect-
ively. Non-normally distributed variables were log-
transformed, and SDS were calculated. For categorical
outcomes, we calculated prevalences of adverse outcomes
among SGA, AGA, and LGA newborns, by dividing the
number of cases by the number of newborns in each birth
weight category. Finally, we assessed the predictive per-
formance of both classifications for the prediction of the
risk of long-term adverse health outcomes among SGA
and LGA newborns by calculating receiver operating
characteristic (ROC) curves, the corresponding area under
the curve, and sensitivity at a 90% specificity. We did not
adjust our analyses for potentially confounding maternal
characteristics, as customized classification already con-
siders maternal characteristics and we were interested in
comparing the classifications. All analyses were performed
using the Statistical Package of Social Sciences version
24.0 for Windows (IBM Corp., Armonk, NY, USA).
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Results
Population characteristics
Table 1 shows population characteristics. Compared to
newborns classified as AGA by customized charts, new-
borns classified as SGA by customized charts more often
had heavier mothers and their mothers more often
smoked throughout pregnancy. They were more often
born premature or with a low APGAR score. Newborns
classified as LGA by customized charts more often had
multiparous mothers, compared to newborns classified
as AGA by customized charts. Compared to newborns
classified as AGA by population charts, newborns classi-
fied as SGA by population charts more often had
nulliparous mothers and mothers with a lower weight
and their mothers more often smoked throughout preg-
nancy. They were also more often born premature or
with a low APGAR score. Newborns classified as LGA
by population charts had heavier mothers and mothers
who were multiparous, compared to newborns classified
as AGA by population charts.
Characteristics of newborns classified as SGA or LGA by
customized or population charts only
Table 2 shows that of 605 newborns classified as SGA
using population charts, 150 (24.8%) were reclassified as
AGA using customized charts, whereas of 605 newborns
Table 1 Maternal and birth characteristics of newborns classified as SGA, AGA, or LGA by customized and population birth weight
classifications
Customized classificationa Population classificationb
Small size for
gestational age
Appropriate size for
gestational age
Large size for
gestational age
Small size for
gestational age
Appropriate size for
gestational age
Large size for
gestational age
n = 605 n = 4842 n = 605 n = 605 n = 4842 n = 605
Maternal characteristics
Age, median (95% range),
years
30.5 (19.7 to 39.8) 30.6 (19.6 to 39.1) 30.7 (20.1 to 39.3) 29.7 (19.0 to
39.6)
30.5 (19.8 to 39.0) 31.6 (21.5 to
39.8)
Height, mean (SD) (cm) 166.2 (7.4) 167.7 (7.4) 169.3 (7.3) 164.3 (7.1) 167.7 (7.3) 170.6 (7.2)
Weight, mean (SD) (kg) 71.8 (16.3) 68.7 (12.3) 70.4 (12.9) 64.8 (12.5) 68.8 (12.4) 76.0 (14.6)
Body mass index, mean
(SD) (kg/m2)
26 (5.6) 24.4 (4.1) 24.6 (4.4) 24.0 (4.4) 24.5 (4.2) 26.2 (5.1)
Obesity 123 (20.3) 485 (10.0) 60 (9.9) 58 (9.6) 491 (10.1) 119 (19.7)
Education, no. higher (%) 217 (37) 2137 (45) 306 (52) 206 (34.8) 2141 (45.2) 313 (52.8)
Ethnicity, no. (%) Dutch/
European
332 (54.9) 2899 (59.9) 395 (65.3) 283 (46.8) 2911 (60.1) 432 (71.4)
Parity, no. Nulliparous (%) 348 (57.5) 2792 (57.7) 330 (54.5) 434 (71.7) 2787 (57.6) 249 (41.2)
Smoking, no. (%)
None 440 (66.3) 3755 (73.9) 510 (79.6) 379 (65.2) 3466 (74.4) 462 (79.4)
Early pregnancy only 50 (7.5) 453 (8.9) 61 (9.5) 45 (7.7) 418 (9.0) 55 (9.5)
Continued 174 (26.2) 875 (17.2) 70 (10.9) 157 (27.0) 773 (16.6) 65 (11.2)
Birth characteristics
Males, no. (%) 295 (42.8) 2665 (50.5) 390 (59.2) 242 (40.0) 2435 (50.3) 362 (59.8)
Gestational age, median
(95% range) weeks
39.7 (32.0 to 42.3) 40.3 (36.3 to 42.3) 39.9 (36.2 to 42.1) 40.3 (36.3 to
42.4)
40.3 (36.3 to 42.4) 39.9 (36.0 to
42.0)
Birth weight, mean (SD)
grams
2622 (483) 3440 (425) 4176 (396) 2581 (421) 3442 (416) 4230 (399)
Preterm birth, no. (%) 74 (12.2) 184 (3.8) 21 (3.5) 66 (10.9) 187 (3.9) 26 (4.3)
Cesarean delivery, no. (%) 107 (18.9) 467 (10.5) 94 (17.1) 102 (18.2) 478 (10.8) 88 (16.0)
Assisted delivery, no. (%) 75 (13.3) 644 (14.5) 75 (13.6) 59 (15.9) 651 (14.7) 54 (9.9)
APGAR score below 7 at
5 min, no. (%)
16 (2.8) 40 (0.9) 4 (0.9) 12 (2.1) 44 (0.9) 5 (0.9)
Values are median (95% range), mean (SD), and absolute numbers (%)
SD standard deviation
aSGA was defined as gestational age-adjusted birth weight < 10th percentile of the customized chart. AGA is defined as gestational age-adjusted birth weight >
10th and < 90th percentile according to the customized chart. LGA was defined as gestational age-adjusted birth weight > 90th percentile of the
customized chart
bSGA was defined as gestational age-adjusted birth weight < 10th percentile of the population chart. AGA is defined as gestational age-adjusted birth weight >
10th and < 90th percentile of the population chart. LGA was defined as gestational age-adjusted birth weight > 90th percentile of the population chart
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classified as LGA using population charts, 129 (21.3%)
cases were reclassified as AGA using customized charts.
Mothers of newborns who were classified SGA as by
customized charts only were likely to have higher BMIs
and to be of Dutch or European ethnicity and were more
often multiparous compared to mothers of newborns
classified as SGA by both customized and population
charts (Table 3). Newborns classified as SGA by custom-
ized charts only had a higher birth weight and were less
likely to be born preterm and after assisted delivery
compared to newborns classified as SGA by both cus-
tomized and population charts. Mothers of newborns
classified as LGA by customized charts only had lower
age and BMI, were more often of Dutch or European
ethnicity, and were more often nulliparous, compared to
mothers of newborns classified as LGA by customized
and population charts. Newborns classified as LGA by
customized charts only had lower birth weight and were
more likely born after assisted delivery compared to
newborns classified as LGA by both charts. Mothers of
newborns who were classified as SGA by population
charts only were younger, less likely to be obese, of
Dutch or European ethnicity, and to be nulliparous
compared to mothers of newborns classified as SGA by
both charts (Additional file 1: Table S1). Their newborns
showed similar patterns to newborns classified as SGA
by customized charts only. Mothers of newborns classi-
fied as LGA by population charts only were older, had
higher BMI, and were more likely multiparous, and their
newborns had lower birth weight compared to newborns
classified as LGA using both charts.
Customized and population birth weight classification
and childhood outcomes
Based on customized charts, newborns classified as SGA
had a higher risk of infant catch-up-growth compared to
newborns classified as AGA (odds ratio (OR) 5.15 (95%
confidence interval (CI) 4.22 to 6.29), Fig. 1a). Risk of
catch-down growth was higher among newborns classi-
fied as LGA using customized charts, compared to
newborns classified as AGA (OR 3.84 (95% CI 3.22 to
4.59), Fig. 1b). We observed similar associations when
birth weight was classified using population charts.
Compared to newborns classified as AGA, newborns
classified as SGA using customized charts had higher
risks of high childhood blood pressure (OR 2.05 (95% CI
1.55 to 2.72)) and clustering of cardio-metabolic risk fac-
tors (OR 1.66 (95% CI 1.18 to 2.34)). They also tended
to have higher risk of childhood overweight (OR 1.24
(95% CI 0.95 to 1.60)), hyperlipidemia (OR 1.25 (95% CI
0.88 to 1.79)), and liver steatosis (OR 1.77 (95% CI 0.88
to 3.54)), but these findings did not reach statistical sig-
nificance (Fig. 1c–g). We observed similar associations
when we used the population classification. Newborns
classified as LGA using customized charts did not have
increased risks of any adverse cardio-metabolic outcome.
Newborns classified as LGA using population charts had
higher risk of overweight (OR 1.29 (95% CI 1.00 to
1.67)) and a lower risk of hyperlipidemia (OR 0.57 (95%
CI 0.36 to 0.90)) compared with newborns classified as
AGA, but the differences in effect estimates compared
to customized charts were very small. No associations of
newborns classified as SGA or LGA using either classifi-
cation with asthma was found. When we repeated the
analyses among newborns classified as SGA or LGA by
customized or population charts only, largely similar
findings were observed. We only observed a slightly
higher risk of high childhood blood pressure (OR 2.17
(95% CI 1.31 to 3.58)) among newborns classified as
SGA by customized charts only compared to those
classified as SGA by population charts only (Fig. 2).
Additional file 1: Table S2 shows AUCs and derived
Table 2 Agreement of classification of gestational age-adjusted birth weight by customized and population birth weight classifications
Customized classificationa
Small size for
gestational age
n = 605
Appropriate size for
gestational age
n = 4842
Large size for
gestational age
n = 605
Population classificationb Small size for gestational
age
n = 605
455
(75.2)
150
(24.8)
0
(0)
Appropriate size for
gestational age
n = 4842
150
(24.8)
4563
(94.2)
129
(21.3)
Large size for gestational
age
n = 605
0
(0)
129
(21.3)
476
(78.7)
Values are absolute cases (%)
aSGA was defined as gestational age-adjusted birth weight < 10th percentile of the customized chart. AGA is defined as gestational age-adjusted birth weight >
10th and < 90th percentile according to the customized chart. LGA was defined as gestational age-adjusted birth weight > 90th percentile of the
customized chart
bSGA was defined as gestational age-adjusted birth weight < 10th percentile of the population chart. AGA is defined as gestational age-adjusted birth weight >
10th and < 90th percentile of the population chart. LGA was defined as gestational age-adjusted birth weight > 90th percentile of the population chart
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sensitivities at a 90% specificity for both classifications
for the risk of each long-term adverse health outcome.
Both classifications had a poor to moderate ability to
discriminate between those with and those without
long-term adverse health outcomes with AUCs (95% CI)
ranging from 0.51 (95% CI 0.48–0.54) and 0.51 (95% CI
0.48–0.54) for risk of childhood asthma diagnosis to 0.66
(95% CI 0.64–0.69) and 0.63 (95% CI 0.61–0.65) for risk
of infant catch-up growth for customized and population
charts, respectively.
Results presented in the supplementary materials show
associations of birth weight using both customized and
population classifications with continuously measured
blood pressure, lipid, glucose and insulin concentrations,
and lung function (Additional file 1: Table S3–S5).
Altogether, no differences in associations were observed
between effect estimates based on customized or popula-
tion birth weight classifications.
Discussion
Our findings suggest that newborns born SGA have
increased risks of an adverse cardio-metabolic profile at
school age. Newborns born LGA have an increased risk
of catch-down growth. Similar associations were present
for classifications using customized charts and population
charts, which suggests that customized charts are not
superior to population charts at identification of SGA
newborns at increased risk of adverse cardio-metabolic
and respiratory outcomes at later age.
Table 3 Maternal and birth characteristics of SGA or LGA newborns by customized charts only compared to newborns classified as
SGA or LGA by both classifications
Small size for gestational age Large size for gestational age
Customized
onlya
Customized and
populationb
p value Customized
onlya
Customized and
populationb
p value
n = 150 n = 455 n = 129 n = 476
Maternal characteristics
Age, median (95% range), years 30.5 (20.4 to
39.0)
30.5 (19.6 to 40.3) 0.215 27.7 (19.9 to
36.0)
31.2 (20.7 to 40.0) < 0.001
Height, mean (SD) (cm) 169.0 (7.8) 165.3 (7.0) < 0.001 165.7 (6.4) 170.3 (7.2) < 0.001
Weight, mean (SD) (kg) 85.4 (18.1) 67.3 (12.8) < 0.001 60.8 (7.6) 72.9 (12.8) < 0.001
Body mass index, mean (SD) (kg/m2) 30.0 (6.5) 24.6 (4.6) < 0.001 22.2 (2.5) 25.2 (4.6) < 0.001
Obesity, no. (%) 67 (44.7) 56 (12.3) < 0.001 2 (1.6) 58 (12.2) < 0.001
Education, no. higher (%) 51 (34.0) 166 (36.5) 0.582 57 (44.2) 249 (52.3) 0.102
Race/ethnicity, no. (%) Dutch or
European
101 (67.3) 253 (55.6) 0.011 56 (43.4) 327 (68.7) < 0.001
Parity, no. nulliparous (%) 50 (33.3) 298 (65.5) < 0.001 108 (83.7) 222 (46.6) < 0.001
Smoking, no. (%) 0.055 0.711
None 109 (75.2) 282 (64.5) 100 (80.0) 366 (79.2)
Early pregnancy only 9 (6.2) 33 (7.6) 14 (11.2) 45 (9.7)
Continued 27 (18.6) 122 (27.9) 11 (8.8) 51 (11.0)
Birth characteristics
Males, no. (%) 67 (44.7) 185 (40.7) 0.388 72 (55.8) 281 (59.0) 0.511
Gestational age, median (95% range),
weeks
40.1 (32.6 to
42.4)
39.6 (31.9 to 42.3) 0.007 40.0 (36.4 to
42.4)
39.9 (36.1 to 42.0) 0.058
Birth weight, mean (SD) grams 2981 (412) 2503 (445) < 0.001 3922 (319) 4245 (386) < 0.001
Preterm birth, no. (%) 12 (8.0) 62 (13.6) 0.068 3 (2.3) 18 (3.8) 0.423
Cesarean delivery, no. (%) 19 (13.4) 88 (20.8) 0.051 20 (16.7) 74 (17.2) 0.897
Assisted delivery, no. (%) 9 (6.3) 66 (15.6) 0.005 27 (22.5) 48 (11.1) 0.001
APGAR score below 7 at 5 min, no. (%) 5 (3.4) 11 (2.5) 0.549 0 (0) 5 (1.1) 0.237
Values are median (95% range), mean (SD), and absolute numbers (%), and p values for comparison between population only and customized and population
classification. Continuous variables were tested using ANOVA; categorical variables were tested using Chi2 tests
SD standard deviation
aAs defined by the population birth weight classification, but appropriately sized according to customized birth weight classification
bAs defined by the both customized and population birth weight classification
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Fig. 1 (See legend on next page.)
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Interpretation of main findings
Birth weight is a strong determinant of neonatal health
and health in later life [3]. Both experimental studies
and large population studies have suggested that new-
borns born SGA or LGA as results of adverse fetal
exposures experience developmental adaptations which
put them at increased risks of adverse health outcomes
in later life [3, 27]. Thus, identification of newborns with
abnormal size at birth is important to identify individ-
uals who might benefit from preventive strategies from
early life onwards to prevent chronic diseases through-
out the life course. Customized charts have been a topic
of research for several decades as these charts may
identify a higher proportion of newborns that are patho-
logically SGA or LGA and at increased risk of adverse
outcomes, compared to population charts which may
identify both constitutionally and pathologically SGA or
LGA newborns [8, 9].
Previous studies mainly focused on the effects of
customization on selecting newborns at risk for adverse
perinatal outcomes. A meta-analysis including 20 studies
comparing the effectiveness of customized versus popula-
tion charts for prediction of adverse perinatal outcomes
has shown similar effect estimates for associations of
abnormal size at birth with intra-uterine fetal demise,
neonatal intensive care unit admission, and neonatal and
perinatal death [10]. A recent population-based linkage
study among 979,912 singleton pregnancies in the UK
between 1992 and 2010 assessed the predictive ability of
non-customized versus partially customized birth weight
centiles for the prediction of the risks of stillbirth, infant
death, and neonatal morbidity. This study showed that
partial customization of birth weight charts does not im-
prove the prediction of these perinatal complications [28].
For the partial customization, maternal height, parity, and
fetal sex were used. Contrary, analysis of data on live
births and stillbirths in England and Wales between 2007
and 2012 from the Office of National Statistics suggested
in areas that implemented customized charts, a decline in
stillbirth rates of 19% occurred, while stillbirth rates
remained the same in areas that did not implement
customized charts [8, 29]. However, these findings need to
be interpreted carefully, and causality cannot be estab-
lished from these observational studies. Recently, a study
across different countries in Europe, including the UK,
performed between 2004 and 2010 showed that rates of
stillbirths declined by an average of 17%. A large number
of these countries did not implement the use of custom-
ized charts. Thus, in comparison by the overall decline in
stillbirth rates in Europe, the difference in decline in
stillbirth rates in areas with and without implementation
of customized charts may be relatively small [29, 30]. To
date, no studies compared the use of customized and
population charts to identify newborns at risk of long-
term adverse health outcomes. We observed that custom-
ized charts were not better at selecting newborns at risk of
adverse long-term cardio-metabolic or respiratory out-
comes compared to population charts. As the majority of
SGA newborns are classified as such by both charts, the
benefit of the customized classification would mainly be
present among the small group of newborns reclassified as
having a normal or abnormal size for gestational age at
birth by the customized charts. Within our study, new-
borns classified as SGA by customized charts only did
have higher risk of high blood pressure compared to AGA
newborns and all SGA newborns, but these effects were
not large enough to lead to a significant benefit of the use
of customized over population charts. Thus, overall our
study does not provide strong evidence for the use of
customized charts to better identify newborns at risk of
long-term adverse health outcomes. When we determined
the accuracy of both classification methods for the predic-
tion of individual risk of adverse outcomes, we observed a
poor to moderate performance for both customized and
population charts. This suggests that neither classification
can be used for individual prediction of the risk for long-
term adverse health outcomes based on classifying size at
birth. However, the apparent increased risk of long-term
(See figure on previous page.)
Fig. 1 a–h Prevalence of birth weight classifications and their association with infant growth patterns and cardio-metabolic and respiratory outcomes
at age 10.
Bars are prevalence (%, left y-axis) and OR’s (95% CI, right y-axis). Reference groups for OR’s of customized and population classifications are newborns
classified AGA according to the respective classification. Prevalences of adverse outcomes among SGA, AGA and LGA newborns were calculated by
dividing the number of cases by the number of newborns in each birth weight category.
Clustering of cardio-metabolic risk factors is defined as having three or more of the following components: visceral fat mass >75th percentile; systolic
or diastolic blood pressure >75th percentile; HDL-cholesterol <25th percentile or triglycerides >75th percentile; and insulin level >75th percentile of our
study population.
a SGA was defined as gestational age adjusted birth weight <10th percentile of the customized chart. AGA is defined as gestational age adjusted birth
weight >10th and <90th percentile of the customized chart. LGA was defined as gestational age adjusted birth weight >90th percentile of the
customized chart.
b SGA was defined as gestational age adjusted birth weight <10th percentile of the population birth weight chart. AGA is defined as gestational age
adjusted birth weight >10th and <90th percentile the population chart. LGA was defined as gestational age adjusted birth weight >90th percentile of
the population chart
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adverse health outcomes among the group of SGA new-
borns, classified using either classification, suggests that
on a population level this characteristic can be used for
screening or prevention strategies, especially in combin-
ation with other prognostic factors.
There are several reasons why we might not observe
strong differences in risks of long-term adverse out-
comes between birth weights classified using customized
or population charts. First, current customized birth
weight charts have been criticized as they might not yet
capture growth potential well enough to truly differenti-
ate between pathologically and constitutionally SGA and
LGA newborns [11, 31]. This would explain why we did
not observe a clear benefit of customized charts over
population charts for the identification of newborns at
risk of adverse outcomes in later life. Future studies
should determine whether customized charts can be
improved by removal or addition of other parameters
associated with fetal size and birth outcomes, such as pa-
rameters of placental vascular resistance or biomarkers
[32, 33]. Second, it has been hypothesized that the
observed stronger associations of abnormal fetal size or
size at birth for gestational age based on customized
charts with adverse perinatal outcomes could be ex-
plained by confounding, for example by preterm birth
and maternal obesity [11]. In a previous study among
4095 women and their offspring, obesity and preterm
birth were more prevalent among mothers of newborns
classified as SGA using customized charts [11]. Associa-
tions with adverse outcomes attenuated after adjustment
for maternal obesity and preterm birth. In our study,
prevalence of obesity among mothers of newborns clas-
sified as SGA using customized charts was twice that of
mothers of newborns classified as SGA using population
charts. Among newborns classified as SGA using cus-
tomized charts only, maternal obesity was even fourfold
higher, which might explain a tendency for larger effect
sizes for risk of childhood overweight, high blood pres-
sure, and clustering of cardio-metabolic risk factors. Thus,
small differences in effect estimates between associations
of SGA classified by customized and population charts
might be explained by confounding factors. Finally, we
might not have found strong differences in risk of adverse
outcomes between customized and population charts,
because our population is relatively healthy. We did not
have extreme cases of SGA or LGA, and the prevalence of
long-term adverse health outcomes is low within our
cohort. The potential advantage of the use of customized
charts might be stronger among higher-risk populations.
Further studies in these populations are needed.
Based on the findings in our study and the fact that
population charts are easier to use and widely imple-
mented, we would not recommend implementation of
customized birth weight charts for identification of
newborns at risk of long-term adverse health outcomes.
Strengths and limitations
We had a prospective data collection from early preg-
nancy onwards and a large sample of 6052 newborns
available with detailed childhood growth, cardio-
metabolic, and respiratory measurements. Loss to follow-
up could have reduced statistical power and led to biased
effect estimates if associations differ between children
included and not included in the analysis. We do not
think this poses a problem within our study, as the aim of
our study was to compare two classification methods.
The non-response at baseline might have led to selec-
tion of a healthier population, which might affect the
generalizability of our results to higher-risk populations. In
clinical practice, often sex-specific population charts
are used to classify abnormal size at birth weight. Given
the aim of our study to specifically assess the effect of
customization by major determinants of fetal growth,
we constructed a population chart which included
(See figure on previous page.)
Fig. 2 a–h Prevalence of customized only and population only birth weight classifications and their association with infant growth patterns and
cardio-metabolic and respiratory outcomes at age 10.
Bars are prevalence (%, left y-axis) and OR’s (95% CI, right y-axis). Reference groups for OR’s of customized and population classifications are
newborns classified AGA according to both customized and population classification.
Prevalences of adverse outcomes among SGA, AGA and LGA newborns were calculated by dividing the number of cases by the number of
newborns in each birth weight category.
Clustering of cardio-metabolic risk factors is defined as having three or more of the following components: visceral fat mass >75th percentile;
systolic or diastolic blood pressure >75th percentile; HDL-cholesterol <25th percentile or triglycerides >75th percentile; and insulin level >75th
percentile of our study population.
a SGA was defined as gestational age adjusted birth weight <10th percentile of the customized chart, but >10th percentile according to the
population chart. AGA is defined as gestational age adjusted birth weight >10th and <90th percentile of both the customized and population
chart. LGA was defined as gestational age adjusted birth weight >90th percentile of the customized chart, but not <90th percentile according to
the population chart.
b SGA was defined as gestational age adjusted birth weight <10th percentile of the population birth weight chart, but >10th percentile according
to the customized chart. AGA is defined as gestational age adjusted birth weight >10th and <90th percentile of both the population and
customized chart. LGA was defined as gestational age adjusted birth weight >90th percentile of the population chart, but not <90th percentile of
the customized chart
Erkamp et al. BMC Medicine          (2019) 17:186 Page 10 of 12
gestational age only to enable the most optimal com-
parison. By including fetal sex in the population chart,
we could underestimate the effect of customized charts,
as fetal sex is one of the major physiological determi-
nants of fetal growth. If we had included fetal sex in
our population charts, we expect similar or even weaker
differences between the associations of abnormal size at
birth with the risk of long-term adverse outcomes
according to customized charts and population charts.
Which maternal factors should be included in the
customized charts also remains debatable. We included
the pathological variable maternal smoking in the con-
struction of the model to obtain a better fitted model.
For the construction of a customized growth chart, the
term for smoking was set to zero, whether the pregnant
woman smoked or not, and thereby, non-smoking was
used as reference category within our customized
model for all women. This approach still allowed us to
detect pathological fetal growth restriction due to ma-
ternal smoking during pregnancy. A similar approach
may also be used for other pathological variables and
further improve customized charts. Further studies are
needed to explore whether customized charts which
consider more maternal factors improve the classifica-
tion of size at birth. Blood sample collection was
performed in a non-fasting state at different time points
in the day. Since glucose and insulin levels are sensitive
towards carbohydrate intake and vary during the day,
this may have led to non-differential misclassification
and an underestimation of the observed effect estimates.
Conclusion
SGA newborns seem to be at risk of long-term adverse
cardio-metabolic health outcomes, irrespective of use of
customized or population birth weight charts. Our results
suggest that customized charts are not superior to popula-
tion charts at selecting newborns at risk of adverse child-
hood growth, cardio-metabolic, and respiratory outcomes.
Based on these findings, we do not recommend imple-
mentation of customized charts for selection of newborns
at risk of long-term adverse outcomes.
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